Intracellular GSH content of liver and small intestine after the bioavailability study over 48 h.
| Tissue | Control | BSO Treatment |
|---|---|---|
| Wistar liver | 6.64 ± 0.58 (100 ± 8.7) | 1.63 ± 0.30 (24.5 ± 5.0) |
| Wistar intestine | 1.8 ± 1.1 (100 ± 15.35) | 0.10 ± 0.02 (5.6 ± 1.1) |
| TR− liver | 10.4 ± 0.31-a (157 ± 4.5) | N.D. |
| TR− intestine | 3.1 ± 0.3 (173.2 ± 17.3) | N.D. |
Data are given in micromoles per gram of tissue (percentage of untreated Wistar rats in brackets) and represent means ± SD of four independent experiments
↵1-a Paulusma et al., 1999.